Top

World Journal of Urology

Published in:

01-02-2010 | Original Article

Partners agree that the treatment of LUTS reduces patients’ bother and improves their quality of life: prospective 12 years follow-up study

Authors: Said Fadel Mishriki, Samuel J. S. Grimsley, Ghulam Nabi, Nicholas Paul Cohen

Published in: World Journal of Urology | Issue 1/2010

Abstract

Objectives

To determine if the partner (partner or spouse) can reliably assess the quality of life (QoL) and bother of the patient suffering from lower urinary tract symptoms (LUTS) before and after treatment thereby assisting in management.

Methods

458 men referred with LUTS to a university hospital and 219 partners were recruited into the study between January 1993 and September 1994. Assessment included AUA score, flow rates, QoL and bother validated self-reported questionnaires completed by patients and spouses throughout the study. Data were collected at baseline, 3, 6 months, 6 and 12 years of follow-up. 280 men underwent TURP and 178 were managed by medical (non-surgical) treatment.

Results

For the TURP group, the mean QoL for patient and partner at baseline were 8.16 and 9.90 respectively. At 6 months, 6 and 12 years, these improved to 2.43, 3.71, 3.74 and 1.76, 4.07, 4.76 respectively. For the non-surgical treatment group, the mean QoL for patient and partner at baseline were 7.08 and 8.35 respectively. At 6 months, 6 and 12 years, these improved to 5.0, 3.6, 3.28 and 5.67, 3.61, 2.81 respectively. A similar trend applied to the bother score. Improvements in QoL and bother noted by partners agreed with that of patients and were statistically significant.

Conclusions

The longest prospective in-depth study has shown marked conformity between patients and partners regarding QoL and bother after treatment. Partners are affected by patients’ LUTS, appreciate the improvement after treatment and may be valuable contributors in assessment.

Available only for authorised users

Irwin DE, Milsom I, Hunskaar S, Reilly K, Kopp Z, Herschorn S, Coyne K, Kelleher C, Hampel C, Artibani W, Abrams P (2006) Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol 50:1306–1314CrossRefPubMed

Roehrborn CG, Marks L, Harkaway R (2006) Enlarged prostate: a landmark national survey of its prevalence and impact on US men and their partners. Prostate Cancer Prostatic Dis 9:30–34CrossRefPubMed

Trueman P, Hood SC, Nayak US, Mrazek MF (1999) Prevalence of lower urinary tract symptoms and self-reported diagnosed ‘benign prostatic hyperplasia’, and their effect on quality of life in a community-based survey of men in the UK. BJU Int 83:410–415CrossRefPubMed

Sells H, Donovan J, Ewings P, MacDonagh RP (2000) The development and validation of a quality-of-life measure to assess partner morbidity in benign prostatic enlargement. BJU Int 85:440–445CrossRefPubMed

Shvartzman P, Borkan JM, Stoliar L, Peleg A, Nakar S, Nir G, Tabenkin H (2001) Second-hand prostatism: effects of prostatic symptoms on spouses’ quality of life, daily routines and family relationships. Fam Pract 18:610–613CrossRefPubMed

Mitropoulos D, Anastasiou I, Giannopoulou C, Nikolopoulos P, Alamanis C, Zervas A, Dimopoulos C (2002) Symptomatic benign prostate hyperplasia: impact on partners’ quality of life. Eur Urol 41:240–244CrossRefPubMed

Barry MJ, Fowler FJ Jr, O’Leary MP, Bruskewitz RC, Holtgrewe HL, Mebust WK (1992) American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. J Urol 148:1549–1557PubMed

Boyle P, Robertson C, Mazzetta C, Keech M, Hobbs FD, Fourcade R, Kiemeney L, Lee C (2003) The prevalence of male urinary incontinence in four centres: the UREPIK study. BJU Int 92:943–947CrossRefPubMed

Mishriki SF, Grimsley SJ, Nabi G, Martindale A, Cohen NP (2008) Improved quality of life and enhanced satisfaction after TURP: prospective 12-year follow-up study. Urology 72:322–326 (discussion 326)CrossRefPubMed

10.

Boyle P, Robertson C, Mazzetta C, Keech M, Hobbs R, Fourcade R, Kiemeney L, Lee C (2003) The relationship between lower urinary tract symptoms and health status: the UREPIK study. BJU Int 92:575–580CrossRefPubMed

11.

Welch G, Weinger K, Barry MJ (2002) Quality-of-life impact of lower urinary tract symptom severity: results from the Health Professionals Follow-up Study. Urology 59:245–250CrossRefPubMed

12.

Zwergel U, Wullich B, Lindenmeir U, Rohde V, Zwergel T (1998) Long-term results following transurethral resection of the prostate. Eur Urol 33:476–480CrossRefPubMed

13.

Mishriki SF, Cohen NP, Mawas A, Banerjee G, Golash A, Mason R, Sutherland A (2001) LUTS bother partners too. BJU 88(Suppl 1):58

14.

Roehrborn CG, Boyle P, Nickel JC, Hoefner K, Andriole G (2002) Efficacy and safety of a dual inhibitor of 5-apha-reductase types 1 and 2 (dutasteride) in men with benign prostatic hyperplasia. Urology 60:434–441CrossRefPubMed

15.

McConnell JD, Bruskewitz R, Walsh P, Andriole G, Lieber M, Holtgrewe HL, Albertsen P, Roehrborn CG, Nickel JC, Wang DZ, Taylor AM, Waldstreicher J (1998) The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia. N Engl J Med 338:557–563CrossRefPubMed

16.

de la Rosette JJ, Kortmann BB, Rossi C, Sonke GS, Floratos DL, Kiemeney LA (2002) Long-term risk of re-treatment of patients using alpha-blockers for lower urinary tract symptoms. J Urol 167:1734–1739CrossRef

17.

Marklund-Bau H, Edéll-Gustafsson U, Spångberg A (2008) A Swedish version of a quality of life questionnaire for partners of men with symptoms suggestive of benign prostatic obstruction. Scand J Urol Nephrol 42:126–131CrossRefPubMed

18.

MacDonagh RP, Cliff AM, Speakman MJ, O’Boyle PJ, Ewings P, Gudex C (1997) The use of generic measures of health-related quality of life in the assessment of outcome from transurethral resection of the prostate. Br J Urol 79:401–408PubMed

19.

Fowler FJ Jr, Wennberg JE, Timothy RP, Barry MJ, Mulley AG Jr, Hanley D (1988) Symptom status and quality of life following prostatectomy. JAMA 259:3018–3022CrossRefPubMed

Title: Partners agree that the treatment of LUTS reduces patients’ bother and improves their quality of life: prospective 12 years follow-up study
Authors: Said Fadel Mishriki
Samuel J. S. Grimsley
Ghulam Nabi
Nicholas Paul Cohen
Publication date: 01-02-2010
Publisher: Springer-Verlag
Published in: World Journal of Urology / Issue 1/2010
Print ISSN: 0724-4983
Electronic ISSN: 1433-8726
DOI: https://doi.org/10.1007/s00345-009-0449-2

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Partners agree that the treatment of LUTS reduces patients’ bother and improves their quality of life: prospective 12 years follow-up study

Abstract

Objectives

Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Objectives

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2010

Penile block is associated with less urinary retention than caudal anesthesia in distal hypospadia repair in children

Thulium:YAG laser enucleation (VapoEnucleation) of the prostate: safety and durability during intermediate-term follow-up

Role of voiding and storage symptoms for the quality of life before and after treatment in men with voiding dysfunction

Sildenafil citrate and tamsulosin combination is not superior to monotherapy in treating lower urinary tract symptoms and erectile dysfunction

New therapies for non-muscle-invasive bladder cancer

Current status of 5α-reductase inhibitors in the management of lower urinary tract symptoms and BPH